Information Journal Paper
APA:
Copy. (2018). Clinical relevance of detecting antiinfliximab antibodies with a drug-tolerant assay: post hoc analysis of the TAXIT trial. GUT, 67(-), 818-826. SID. https://sid.ir/paper/733485/en
Vancouver:
Copy. Clinical relevance of detecting antiinfliximab antibodies with a drug-tolerant assay: post hoc analysis of the TAXIT trial. GUT[Internet]. 2018;67(-):818-826. Available from: https://sid.ir/paper/733485/en
IEEE:
Copy, “Clinical relevance of detecting antiinfliximab antibodies with a drug-tolerant assay: post hoc analysis of the TAXIT trial,” GUT, vol. 67, no. -, pp. 818–826, 2018, [Online]. Available: https://sid.ir/paper/733485/en